Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Market Report 2017

Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Market Report 2017

1 High Performance Active Pharmaceutical Ingredients (HPAPI) Overview

1.1 Product Overview and Scope of High Performance Active Pharmaceutical Ingredients (HPAPI)

1.2 Classification of High Performance Active Pharmaceutical Ingredients (HPAPI) by Product Category

1.2.1 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Sales) Comparison by Types (2012-2022)

1.2.2 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Sales) Market Share by Type (Product Category) in 2016

1.2.3 Synthetic Ingredients

1.2.4 Biological Ingredients

1.2.5 Others

1.3 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Market by Application/End Users

1.3.1 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (Volume) and Market Share Comparison by Applications (2012-2022)

1.3.2 Oncology

1.3.3 Glaucoma

1.3.4 Anti-diabetic

1.3.5 Cardiovascular

1.3.6 Musculoskeletal

1.3.7 Hormonal

1.3.8 Others

1.4 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Market by Region

1.4.1 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Value) Comparison by Region (2012-2022)

1.4.2 China Status and Prospect (2012-2022)

1.4.3 Japan Status and Prospect (2012-2022)

1.4.4 South Korea Status and Prospect (2012-2022)

1.4.5 Taiwan Status and Prospect (2012-2022)

1.4.6 India Status and Prospect (2012-2022)

1.4.7 Southeast Asia Status and Prospect (2012-2022)

1.4.8 Australia Status and Prospect (2012-2022)

1.5 Asia-Pacific Market Size (Value and Volume) of High Performance Active Pharmaceutical Ingredients (HPAPI) (2012-2022)

1.5.1 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Growth Rate (2012-2022)

1.5.2 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate (2012-2022)

2 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Competition by Players/Suppliers, Region, Type and Application

2.1 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Market Competition by Players/Suppliers

2.1.1 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share of Key Players/Suppliers (2012-2017)

2.1.2 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Share by Players/Suppliers (2012-2017)

2.2 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) (Volume and Value) by Type

2.2.1 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Market Share by Type (2012-2017)

2.2.2 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Market Share by Type (2012-2017)

2.3 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) (Volume) by Application

2.4 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) (Volume and Value) by Region

2.4.1 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Market Share by Region (2012-2017)

2.4.2 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Market Share by Region (2012-2017)

3 China High Performance Active Pharmaceutical Ingredients (HPAPI) (Volume, Value and Sales Price)

3.1 China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Value (2012-2017)

3.1.1 China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Growth Rate (2012-2017)

3.1.2 China High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate (2012-2017)

3.1.3 China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price Trend (2012-2017)

3.2 China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Type

3.3 China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Application

4 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) (Volume, Value and Sales Price)

4.1 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Value (2012-2017)

4.1.1 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Growth Rate (2012-2017)

4.1.2 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate (2012-2017)

4.1.3 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price Trend (2012-2017)

4.2 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Type

4.3 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Application

5 South Korea High Performance Active Pharmaceutical Ingredients (HPAPI) (Volume, Value and Sales Price)

5.1 South Korea High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Value (2012-2017)

5.1.1 South Korea High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Growth Rate (2012-2017)

5.1.2 South Korea High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate (2012-2017)

5.1.3 South Korea High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price Trend (2012-2017)

5.2 South Korea High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Type

5.3 South Korea High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Application

6 Taiwan High Performance Active Pharmaceutical Ingredients (HPAPI) (Volume, Value and Sales Price)

6.1 Taiwan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Value (2012-2017)

6.1.1 Taiwan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Growth Rate (2012-2017)

6.1.2 Taiwan High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate (2012-2017)

6.1.3 Taiwan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price Trend (2012-2017)

6.2 Taiwan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Type

6.3 Taiwan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Application

7 India High Performance Active Pharmaceutical Ingredients (HPAPI) (Volume, Value and Sales Price)

7.1 India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Value (2012-2017)

7.1.1 India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Growth Rate (2012-2017)

7.1.2 India High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate (2012-2017)

7.1.3 India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price Trend (2012-2017)

7.2 India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Type

7.3 India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Application

8 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) (Volume, Value and Sales Price)

8.1 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Value (2012-2017)

8.1.1 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Growth Rate (2012-2017)

8.1.2 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate (2012-2017)

8.1.3 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price Trend (2012-2017)

8.2 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Type

8.3 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Application

9 Australia High Performance Active Pharmaceutical Ingredients (HPAPI) (Volume, Value and Sales Price)

9.1 Australia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Value (2012-2017)

9.1.1 Australia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Growth Rate (2012-2017)

9.1.2 Australia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate (2012-2017)

9.1.3 Australia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price Trend (2012-2017)

9.2 Australia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Type

9.3 Australia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Market Share by Application

10 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Players/Suppliers Profiles and Sales Data

10.1 Bristol-Myers Squibb

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

10.1.2.1 Product A

10.1.2.2 Product B

10.1.3 Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)

10.1.4 Main Business/Business Overview

10.2 Novartis

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

10.2.2.1 Product A

10.2.2.2 Product B

10.2.3 Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)

10.2.4 Main Business/Business Overview

10.3 Sanofi Aventis

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

10.3.2.1 Product A

10.3.2.2 Product B

10.3.3 Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)

10.3.4 Main Business/Business Overview

10.4 Pfizer

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

10.4.2.1 Product A

10.4.2.2 Product B

10.4.3 Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)

10.4.4 Main Business/Business Overview

10.5 Lonza

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

10.5.2.1 Product A

10.5.2.2 Product B

10.5.3 Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)

10.5.4 Main Business/Business Overview

10.6 Novasep

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

10.6.2.1 Product A

10.6.2.2 Product B

10.6.3 Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)

10.6.4 Main Business/Business Overview

10.7 Hospira

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

10.7.2.1 Product A

10.7.2.2 Product B

10.7.3 Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)

10.7.4 Main Business/Business Overview

10.8 BASF

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

10.8.2.1 Product A

10.8.2.2 Product B

10.8.3 BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)

10.8.4 Main Business/Business Overview

10.9 Merck

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

10.9.2.1 Product A

10.9.2.2 Product B

10.9.3 Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)

10.9.4 Main Business/Business Overview

10.10 Bayer

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

10.10.2.1 Product A

10.10.2.2 Product B

10.10.3 Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2012-2017)

10.10.4 Main Business/Business Overview

10.11 Teva Pharmaceuticals

10.12 Boehringer Ingelheim

11 High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturing Cost Analysis

11.1 High Performance Active Pharmaceutical Ingredients (HPAPI) Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of High Performance Active Pharmaceutical Ingredients (HPAPI)

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 High Performance Active Pharmaceutical Ingredients (HPAPI) Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of High Performance Active Pharmaceutical Ingredients (HPAPI) Major Manufacturers in 2016

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Market Effect Factors Analysis

14.1 Technology Progress/Risk

14.1.1 Substitutes Threat

14.1.2 Technology Progress in Related Industry

14.2 Consumer Needs/Customer Preference Change

14.3 Economic/Political Environmental Change

15 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Market Forecast (2017-2022)

15.1 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume, Revenue and Price Forecast (2017-2022)

15.1.1 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Growth Rate Forecast (2017-2022)

15.1.2 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate Forecast (2017-2022)

15.1.3 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Price and Trend Forecast (2017-2022)

15.2 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)

15.2.1 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume and Growth Rate Forecast by Region (2017-2022)

15.2.2 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate Forecast by Region (2017-2022)

15.2.3 China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue and Growth Rate Forecast (2017-2022)

15.2.4 Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue and Growth Rate Forecast (2017-2022)

15.2.5 South Korea High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue and Growth Rate Forecast (2017-2022)

15.2.6 Taiwan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue and Growth Rate Forecast (2017-2022)

15.2.7 India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue and Growth Rate Forecast (2017-2022)

15.2.8 Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue and Growth Rate Forecast (2017-2022)

15.2.9 Australia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue and Growth Rate Forecast (2017-2022)

15.3 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue and Price Forecast by Type (2017-2022)

15.3.1 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Forecast by Type (2017-2022)

15.3.2 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Forecast by Type (2017-2022)

15.3.3 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Price Forecast by Type (2017-2022)

15.4 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix

17.1 Methodology/Research Approach

17.1.1 Research Programs/Design

17.1.2 Market Size Estimation

17.1.3 Market Breakdown and Data Triangulation

17.2 Data Source

17.2.1 Secondary Sources

17.2.2 Primary Sources

17.3 Disclaimer

Figure Product Picture of High Performance Active Pharmaceutical Ingredients (HPAPI)

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Type (2012-2022)

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type (Product Category) in 2016

Figure Synthetic Ingredients Product Picture

Figure Biological Ingredients Product Picture

Figure Others Product Picture

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) by Application (2012-2022)

Figure Asia-Pacific Sales Market Share of High Performance Active Pharmaceutical Ingredients (HPAPI) by Application in 2016

Figure Oncology Examples

Table Key Downstream Customer in Oncology

Figure Glaucoma Examples

Table Key Downstream Customer in Glaucoma

Figure Anti-diabetic Examples

Table Key Downstream Customer in Anti-diabetic

Figure Cardiovascular Examples

Table Key Downstream Customer in Cardiovascular

Figure Musculoskeletal Examples

Table Key Downstream Customer in Musculoskeletal

Figure Hormonal Examples

Table Key Downstream Customer in Hormonal

Figure Others Examples

Table Key Downstream Customer in Others

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Market Size (Million USD) by Region (2012-2022)

Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure South Korea High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure Taiwan High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure Australia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) and Growth Rate (2012-2022)

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Market Major Players Product Sales Volume (K MT)(2012-2017)

Table Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) of Key Players/Suppliers (2012-2017)

Table Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Share by Players/Suppliers (2012-2017)

Figure 2016 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Share by Players/Suppliers

Figure 2017 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Share by Players/Suppliers

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Market Major Players Product Revenue (Million USD) 2012-2017

Table Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) by Players/Suppliers (2012-2017)

Table Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Share by Players

Figure 2017 Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Share by Players

Table Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales and Market Share by Type (2012-2017)

Table Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Share by Type (2012-2017)

Figure Sales Market Share of High Performance Active Pharmaceutical Ingredients (HPAPI) by Type (2012-2017)

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate by Type (2012-2017)

Table Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Market Share by Type (2012-2017)

Table Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Share by Type (2012-2017)

Figure Revenue Market Share of High Performance Active Pharmaceutical Ingredients (HPAPI) by Type (2012-2017)

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate by Type (2012-2017)

Table Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) and Market Share by Region (2012-2017)

Table Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Share by Region (2012-2017)

Figure Sales Market Share of High Performance Active Pharmaceutical Ingredients (HPAPI) by Region (2012-2017)

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Region in 2016

Table Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Market Share by Region (2012-2017)

Table Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Share (%) by Region (2012-2017)

Figure Revenue Market Share of High Performance Active Pharmaceutical Ingredients (HPAPI) by Region (2012-2017)

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Region in 2016

Table Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) and Market Share by Application (2012-2017)

Table Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Share (%) by Application (2012-2017)

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Application (2012-2017)

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Application (2012-2017)

Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2017)

Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price (USD/MT) Trend (2012-2017)

Table China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Type (2012-2017)

Table China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type (2012-2017)

Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type in 2016

Table China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Applications (2012-2017)

Table China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application (2012-2017)

Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application in 2016

Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2017)

Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price (USD/MT) Trend (2012-2017)

Table Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Type (2012-2017)

Table Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type (2012-2017)

Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type in 2016

Table Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Applications (2012-2017)

Table Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application (2012-2017)

Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application in 2016

Figure South Korea High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure South Korea High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2017)

Figure South Korea High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price (USD/MT) Trend (2012-2017)

Table South Korea High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Type (2012-2017)

Table South Korea High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type (2012-2017)

Figure South Korea High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type in 2016

Table South Korea High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Applications (2012-2017)

Table South Korea High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application (2012-2017)

Figure South Korea High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application in 2016

Figure Taiwan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure Taiwan High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2017)

Figure Taiwan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price (USD/MT) Trend (2012-2017)

Table Taiwan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Type (2012-2017)

Table Taiwan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type (2012-2017)

Figure Taiwan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type in 2016

Table Taiwan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Applications (2012-2017)

Table Taiwan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application (2012-2017)

Figure Taiwan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application in 2016

Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2017)

Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price (USD/MT) Trend (2012-2017)

Table India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Type (2012-2017)

Table India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type (2012-2017)

Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type in 2016

Table India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Application (2012-2017)

Table India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application (2012-2017)

Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application in 2016

Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2017)

Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price (USD/MT) Trend (2012-2017)

Table Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Type (2012-2017)

Table Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type (2012-2017)

Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type in 2016

Table Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Applications (2012-2017)

Table Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application (2012-2017)

Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application in 2016

Figure Australia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure Australia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2017)

Figure Australia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Price (USD/MT) Trend (2012-2017)

Table Australia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Type (2012-2017)

Table Australia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type (2012-2017)

Figure Australia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Type in 2016

Table Australia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) by Applications (2012-2017)

Table Australia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application (2012-2017)

Figure Australia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share by Application in 2016

Table Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Basic Information List

Table Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share in Asia-Pacific (2012-2017)

Figure Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share in Asia-Pacific (2012-2017)

Table Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Basic Information List

Table Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share in Asia-Pacific (2012-2017)

Figure Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share in Asia-Pacific (2012-2017)

Table Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Basic Information List

Table Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share in Asia-Pacific (2012-2017)

Figure Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share in Asia-Pacific (2012-2017)

Table Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Basic Information List

Table Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share in Asia-Pacific (2012-2017)

Figure Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share in Asia-Pacific (2012-2017)

Table Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Basic Information List

Table Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share in Asia-Pacific (2012-2017)

Figure Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share in Asia-Pacific (2012-2017)

Table Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Basic Information List

Table Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share in Asia-Pacific (2012-2017)

Figure Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share in Asia-Pacific (2012-2017)

Table Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Basic Information List

Table Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share in Asia-Pacific (2012-2017)

Figure Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share in Asia-Pacific (2012-2017)

Table BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Basic Information List

Table BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share in Asia-Pacific (2012-2017)

Figure BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share in Asia-Pacific (2012-2017)

Table Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Basic Information List

Table Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share in Asia-Pacific (2012-2017)

Figure Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share in Asia-Pacific (2012-2017)

Table Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Basic Information List

Table Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate (2012-2017)

Figure Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share in Asia-Pacific (2012-2017)

Figure Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share in Asia-Pacific (2012-2017)

Table Teva Pharmaceuticals High Performance Active Pharmaceutical Ingredients (HPAPI) Basic Information List

Table Boehringer Ingelheim High Performance Active Pharmaceutical Ingredients (HPAPI) Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price (USD/MT) Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of High Performance Active Pharmaceutical Ingredients (HPAPI)

Figure Manufacturing Process Analysis of High Performance Active Pharmaceutical Ingredients (HPAPI)

Figure High Performance Active Pharmaceutical Ingredients (HPAPI) Industrial Chain Analysis

Table Raw Materials Sources of High Performance Active Pharmaceutical Ingredients (HPAPI) Major Manufacturers in 2016

Table Major Buyers of High Performance Active Pharmaceutical Ingredients (HPAPI)

Table Distributors/Traders List

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Price (USD/MT) and Trend Forecast (2017-2022)

Table Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume (K MT) Forecast by Region (2017-2022)

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share Forecast by Region (2017-2022)

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Volume Market Share Forecast by Region in 2022

Table Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) Forecast by Region (2017-2022)

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share Forecast by Region (2017-2022)

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share Forecast by Region in 2022

Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate Forecast (2017-2022)

Figure China High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate Forecast (2017-2022)

Figure Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure South Korea High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate Forecast (2017-2022)

Figure South Korea High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Taiwan High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate Forecast (2017-2022)

Figure Taiwan High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate Forecast (2017-2022)

Figure India High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Australia High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) and Growth Rate Forecast (2017-2022)

Figure Australia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) Forecast by Type (2017-2022)

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share Forecast by Type (2017-2022)

Table Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) Forecast by Type (2017-2022)

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share Forecast by Type (2017-2022)

Table Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Price (USD/MT) Forecast by Type (2017-2022)

Table Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT) Forecast by Application (2017-2022)

Figure Asia-Pacific High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources